Resilience entered into a strategic collaboration with Labcorp to establish a joint customer service offering that provides an end-to-end solution for the preclinical, clinical development and commercial manufacturing of cell and gene therapies (CGT). The collaboration aims to provide streamlined planning with greater flexibility and shared expertise across the drug development continuum and reduced risk of repeat activities. Resilience and Labcorp will jointly work with customers to evalu...